Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) α or ERβ in human osteosarcoma cells: Distinct and common target genes for these receptors

Endocrinology

Volumn 145, Issue 7, 2004, Pages 3473-3486

  Stossi, Fabio ^a   Barnett, Daniel H ^b   Frasor, Jonna ^a   Komm, Barry ^c   Lyttle, C Richard ^c   Katzenellenbogen, Benita S ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; PHYTOESTROGEN;

ARTICLE; CELL LINE; CELL MIGRATION; CELL MOTILITY; CYTOSKELETON; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; GENETIC CODE; GENETIC SELECTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION;

BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; COUMARINS; CYTOKINES; CYTOSKELETON; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOSARCOMA; RECEPTORS, ESTROGEN; TRANSCRIPTION, GENETIC;

EID: 3042681155     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1682     Document Type: Article

References (85)

1. Manolagas SC, Kousteni S, Jilka RL 2002 Sex steroids and bone. Recent Prog Horm Res 57:385-409
2. Manolagas SC 2000 Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-137
3. Riggs BL, Khosla S, Melton 3rd LJ 2002 Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302.
4. Riggs BL, Khosla S, Melton 3rd LJ 1998 A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13:763-773
5. Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G, Martini PGV, McInerney EM, Delage-Mourroux R, Weis K, Katzenellenbogen JA 2000 Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 55:163-195
6. Pettersson K, Gustafsson JA 2001 Role of estrogen receptor β in estrogen action. Annu Rev Physiol 63:165-192
7. McDonnell DP, Norris JD 2002 Connections and regulation of the human estrogen receptor. Science 296:1642-1644
8. McDonnell DP 1999 The molecular pharmacology of SERMs. Trends Endocrinol Metab 10:301-311
9. Klinge CM 2001 Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29:2905-2919
10. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P 2000 Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74:311-317
11. Safe S 2001 Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 62:231-252
12. Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, Gustafsson JA, Safe S 2000 Ligand-, cell-, and estrogen receptor subtype (α/β)- dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 275:5379-5387
13. Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-A, Kushner PJ, Scanlan TS 1997 Differential ligand activation of estrogen receptors ERa and ERb at AP1 sites. Science 277:1508-1510
14. Hall JM, Couse JF, Korach KS 2001 The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276:36869-36872
15. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852
16. McKenna NJ, O'Malley BW 2002 Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465-474
17. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC 2001 Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730
18. Kousteni S, Han L, Chen JR, Almeida M, Plotkin LI, Bellido T, Manolagas SC 2003 Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest 111:1651-1664
19. Kelly MJ, Levin ER 2001 Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12:152-156
20. Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL 1988 Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84-86
21. Hoyland JA, Mee AP, Baird P, Braidman IP, Mawer EB, Freemont AJ 1997 Demonstration of estrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction. Bone 20:87-92
22. Waters KM, Rickard DJ, Riggs BL, Khosla S, Katzenellenbogen JA, Katzenellenbogen BS, Moore J, Spelsberg TC 2001 Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform. J Cell Biochem 83:448-462
23. Bodine PV, Henderson RA, Green J, Aronow M, Owen T, Stein GS, Lian JB, Komm BS 1998 Estrogen receptor-α is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression. Endocrinology 139:2048-2057
24. Arts J, Kuiper GG, Janssen JM, Gustafsson JA, Lowik CW, Pols HA, van Leeuwen JP 1997 Differential expression of estrogen receptors α and β mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology 138:5067-5070
25. Spelsberg TC, Subramaniam M, Riggs BL, Khosla S 1999 The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol 13:819-828
26. McInerney EM, Weis KE, Sun J, Mosselman S, Katzenellenbogen BS 1998 Transcription activation by the human estrogen receptor subtype β (ERβ) studied with ERβ and ERα receptor chimeras. Endocrinology 139:4513-4522
27. Ediger TR, Kraus WL, Weinman EJ, Katzenellenbogen BS 1999 Estrogen receptor regulation of the Na+/H+ exchange regulatory factor. Endocrinology 140:2976-2982
28. Lazennec G, Alcorn JL, Katzenellenbogen BS 1999 Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation. Mol Endocrinol 13:969-980
29. Frasor J, Danes JM, Komm B, Chang K, Lyttle CR, Katzenellenbogen BS 2003 Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144:4562-4574
30. Jelinsky SA, Harris HA, Brown EL, Flanagan K, Zhang X, Tunkey C, Lai K, Lane MV, Simcoe DK, Evans MJ 2003 Global transcription profiling of estrogen activity: estrogen receptor α regulates gene expression in the kidney. Endocrinology 144:701-710
31. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔ C(T)) method. Methods 25:402-408
32. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ 1998 HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795-799
33. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH 1996 Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 157:4741-4745
34. Lanier LL, Corliss B, Wu J, Phillips JH 1998 Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8:693-701
35. Zannettino AC, Buhring HJ, Niutta S, Watt SM, Benton MA, Simmons PJ 1998 The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis. Blood 92:2613-2628
36. Watt SM, Chan JY 2000 CD164 - a novel sialomucin on CD34+ cells. Leuk Lymphoma 37:1-25
37. Chaudhary LR, Avioli LV 1994 Dexamethasone regulates IL-1β and TNF-α-induced interleukin-8 production in human bone marrow stromal and osteoblast-like cells. Calcif Tissue Int 55:16-20
38. Akoum A, Lawson C, McColl S, Villeneuve M 2001 Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro. Mol Hum Reprod 7:859-866
39. Nithipatikom K, Isbell MA, Lindholm PF, Kajdacsy-Balla A, Kaul S, Campell WB 2002 Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion. Clin Exp Metastasis 19:593-601
40. Pedram A, Razandi M, Aitkenhead M, Hughes CC, Levin ER 2002 Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem 277:50768-50775
41. Lee HY, Bae GU, Jung ID, Lee JS, Kim YK, Noh SH, Stracke ML, Park CG, Lee HW, Han JW 2002 Autotaxin promotes motility via G protein-coupled phosphoinositide 3-kinase γ in human melanoma cells. FEBS Lett 515:137-140
42. Jung ID, Lee J, Yun SY, Park CG, Choi WS, Lee HW, Choi OH, Han JW, Lee HY 2002 Cdc42 and Rac1 are necessary for autotaxin-induced tumor cell motility in A2058 melanoma cells. FEBS Lett 532:351-356
43. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J, Arai H 2002 Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158:227-233
44. de Rooij J, Rehmann H, van Triest M, Cool RH, Wittinghofer A, Bos JL 2000 Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J Biol Chem 275:20829-20836
45. Reedquist KA, Ross E, Koop EA, Wolthuis RM, Zwartkruis FJ, van Kooyk Y, Salmon M, Buckley CD, Bos JL 2000 The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J Cell Biol 148:1151-1158
46. Bos JL, De Bruyn K, Enserink J, Kuiperij B, Rangarajan S, Rehmann H, Riedl J, De Rooij J, Van Mansfeld F, Zwartkruis F 2003 The role of Rap1 in integrin-mediated cell adhesion. Biochem Soc Trans 31:83-86
47. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen BS, Katzenellenbogen JA 2000 Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-α- selective agonists. J Med Chem 43:4934-4947
48. Kraichely DM, Sun J, Katzenellenbogen JA, Katzenellenbogen BS 2000 Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-α and estrogen receptor-β: correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology 141:3534-3545
49. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS 2003 Activities of estrogen receptor α- and β-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 206:13-22
50. Harris HA, Katzenellenbogen JA, Katzenellenbogen BS 2002 Characterization of the biological roles of the estrogen receptors, ERα and ERβ, in estrogen target tissues in vivo through the use of an ERα-selective ligand. Endocrinology 143:4172-4177
51. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA 2001 Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44:4230-4251
52. Sun J, Baudry J, Katzenellenbogen JA, Katzenellenbogen BS 2003 Molecular basis for the subtype discrimination of the estrogen receptor-β-selective ligand, diarylpropionitrile. Mol Endocrinol 17:247-258
53. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA 1998 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139:4252-4263
54. Lindberg MK, Moverare S, Eriksson AL, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA, Ohlsson C 2002 Identification of estrogen-regulated genes of potential importance for the regulation of trabecular bone mineral density. J Bone Miner Res 17:2183-2195
55. Mueller SO, Korach KS 2001 Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout mice. Curr Opin Pharmacol 1:613-619
56. Windahl SH, Andersson G, Gustafsson JA 2002 Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol Metab 13:195-200
57. Kumar S, Hand AT, Connor JR, Dodds RA, Ryan PJ, Trill JJ, Fisher SM, Nuttall ME, Lipshutz DB, Zou C, Hwang SM, Votta BJ, James IE, Rieman DJ, Gowen M, Lee JC 1999 Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions. J Biol Chem 274:17123-17131
58. Inadera H, Dong HY, Matsushima K 2002 WISP-2 is a secreted protein and can be a marker of estrogen exposure in MCF-7 cells. Biochem Biophys Res Commun 294:602-608
59. Choi I, Gudas LJ, Katzenellenbogen BS 2000 Regulation of keratin 19 gene expression by estrogen in human breast cancer cells and identification of the estrogen responsive gene region. Mol Cell Endocrinol 164:225-237
60. Yu W, Dahl G, Werner R 1994 The connexin43 gene is responsive to oestrogen. Proc Royal Soc Lond B Biol Sci 255:125-132
61. Pasquini GM, Davey RA, Ho PW, Michelangeli VP, Grill V, Kaczmarczyk SJ, Zajac JD 2002 Local secretion of parathyroid hormone-related protein by an osteoblastic osteosarcoma (UMR 106-01) cell line results in growth inhibition. Bone 31:598-605
62. Horwitz MJ, Tedesco MB, Gundberg C, Garcia-Ocana A, Stewart AF 2003 Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 88:569-575
63. Vic P, Vignon F, Derocq D, Rochefort H 1982 Effect of estradiol on the ultrastructure of the MCF-7 human breast cancer cells in culture. Cancer Res 42:667-673
64. Stossi F, Barnett DH, Frasor J, Katzenellenbogen BS, Transcriptional profiling of estrogen-regulated gene expression in human osteosarcoma cells stably expressing estrogen receptor α or estrogen receptor β. Program of the 85th Annual Meeting of The Endocrine Society, Philadelphia, PA, 2003, p 332 (Abstract P2-106)
65. Hynes RO, Marcantonio EE, Stepp MA, Urry LA, Yee GH 1989 Integrin heterodimer and receptor complexity in avian and mammalian cells. J Cell Biol 109:409-420
66. Isberg RR, Leong JM 1990 Multiple β 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 60:861-871
67. Daemi N, Vallet T, Thomasset N, Jacquier MF, Zebda N, Dore JF, Sordat B, Remy L 1995 Expression of the α 6, β 1 and β 4 integrin subunits, basement membrane organization and proteolytic capacities in low and high metastatic human colon carcinoma xenografts. Invasion Metastasis 15:103-115
68. Hughes FJ, Collyer J, Stanfield M, Goodman SA 1995 The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 136:2671-2677
69. Shen X, Falzon M 2003 PTH-related protein modulates PC-3 prostate cancer cell adhesion and integrin subunit profile. Mol Cell Endocrinol 199:165-177
70. Hoey RP, Sanderson C, Iddon J, Brady G, Bundred NJ, Anderson NG 2003 The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells. Br J Cancer 88:567-573
71. Monroe DG, Getz BJ, Johnsen SA, Riggs BL, Khosla S, Spelsberg TC 2003 Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERα or ERβ. J Cell Biochem 90:315-326
72. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB 2002 Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277:5209-5218
73. Katzenellenbogen BS, Katzenellenbogen JA 2002 Defining the "S" in SERMs. Science 295:2380-2381
74. Zhao YY, Sun KL, Ashok K 1998 Analysis of a cis-acting element involved in regulation by estrogen of human angiotensinogen gene expression. Biochem Biophys 30:445-448
75. Rickard DJ, Hofbauer LC, Bonde SK, Gori F, Spelsberg TC, Riggs BL 1998 Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen. J Clin Invest 101:413-422
76. Ghosh MG, Thompson DA, Weigel RJ 2000 PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res 60:6367-6375
77. Sager R, Anisowicz A, Neveu M, Liang P, Sotiropoulou G 1993 Identification by differential display of α 6 integrin as a candidate tumor suppressor gene. FASEB J 7:964-970
78. Kanda N, Watanabe S 2001 17β-Estradiol, progesterone, and dihydrotestosterone suppress the growth of human melanoma by inhibiting interleukin-8 production. J Invest Dermatol 117:274-283
79. Nolet S, Mbikay M, Chretien M 1991 Prostatic secretory protein PSP94: gene organization and promoter sequence in rhesus monkey and human. Biochim Biophys Acta 1089:247-249
80. Watters JJ, Dorsa DM 1998 Transcriptional effects of estrogen on neuronal neurotensin gene expression involve cAMP/protein kinase A-dependent signaling mechanisms. J Neurosci 18:6672-6680
81. Thiede MA, Harm SC, Hasson DM, Gardner RM 1991 In vivo regulation of parathyroid hormone-related peptide messenger ribonucleic acid in the rat uterus by 17β-estradiol. Endocrinology 128:2317-2323
82. Brown AM, Jeltsch JM, Roberts M, Chambon P 1984 Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci USA 81:6344-6348
83. Thenot S, Charpin M, Bonnet S, Cavailles V 1999 Estrogen receptor cofactors expression in breast and endometrial human cancer cells. Mol Cell Endocrinol 156:85-93
84. Zajchowski DA, Kauser K, Zhu D, Webster L, Aberle S, White 3rd FA, Liu HL, Humm R, MacRobbie J, Ponte P, Hegele-Hartung C, Knauthe R, Fritzemeier KH, Vergona R, Rubanyi GM 2000 Identification of selective estrogen receptor modulators by their gene expression fingerprints. J Biol Chem 275:15885-15894
85. Peddada SD, Lobenhofer EK, Li L, Afshari CA, Weinberg CR, Umbach DM 2003 Gene selection and clustering for time-course and dose-response microarray experiments using order-restricted inference. Bioinformatics 19:834-841